— About Dyno
A clearer starting point.
Testosterone first.
Dyno Health, Inc. is developing at-home testosterone testing. Our aim is simple: make it easier for people to understand their health, wherever they are.
Founded by Charles Denault. Built around a clearer picture of your health.
Our founder
Charles Denault.
Charles Denault is the founder of Dyno Health, Inc., the company behind Dyno's at-home blood testing platform.
Also known as Charles H. Denault III, he previously founded SimpleCharters, a private aviation marketplace that became Camber. Vista Global acquired Camber in 2022.
Today, he is building Dyno to make blood testing more accessible, starting with a single testosterone assay designed for use at home.
What we're building
One assay first.
A broader vision ahead.
Our initial product is a single testosterone assay being developed for at-home finger-prick testing. It does not include a broader hormone panel. Our vision is to make frequent testing easier, with a clear record over time.
The device is investigational and in active development. It is not FDA cleared or approved, and is not available for sale. All performance specifications are design targets that have not yet been validated.
Beyond the first product, we see possibilities for additional at-home assays. Each would require its own development, validation, and any applicable regulatory review. Future applications are separate from the first testosterone product, with no committed scope or timeline.